Medpace Holdings, Inc. Common Stock
$615.18
-$1.26 (-0.20%)
$608.52Day Range$622.25
Key Statistics
Market Cap
$17.21B
Shares Outstanding
27.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 11, 2016
Round Lot
40
Locale
US
Trading Data
Day Open
$620.00
Day High
$622.25
Day Low
$608.52
Volume
226.1K
VWAP
$617.90
Prev Close
$616.44
Transactions
--
Acc. Volume
--
About Medpace Holdings, Inc. Common Stock
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHSIC 87316,500 employees5375 MEDPACE WAY, CINCINNATI, OH, 45227(513) 579-9911IPO Aug 11, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001668397
- Composite FIGI
- BBG0065B7K59
- Share Class FIGI
- BBG0065B7K40
- Ticker Root
- MEDP
- SIC Code
- 8731
About Medpace Holdings, Inc. Common Stock (MEDP) Stock
Medpace Holdings, Inc. Common Stock (MEDP) closed the 2026-09-17 session at $615.18, down 0.20% versus the previous close (-1.26). The stock opened at $620.00 and traded between $608.52 and $622.25 during that session. Session trading volume was 226K shares. The volume-weighted average price (VWAP) is $617.90.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Medpace Holdings, Inc. Common Stock has a market capitalization of $17.21 billion. The company operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry classification. MEDP is listed on the XNAS exchange. The company employs approximately 6,500 people. Medpace Holdings, Inc. Common Stock is headquartered in CINCINNATI, OH. The recorded listing date is 2016-08-11.
On this page you can find market MEDP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.